The Intrarenal Renin-Angiotensin and Dopaminergic Systems: Control of Renal Sodium Excretion and Blood Pressure

R. Carey

DOI: https://doi.org/10.1161/HYPERTENSIONAHA.111.00241

IF: 9.8968

2013-03-01

Hypertension

Abstract:The renin-angiotensin system (RAS) is a coordinated hormonal cascade critical to the control of renal sodium (Na+) excretion and blood pressure (BP) (1). Angiotensin II (Ang II), the principal RAS effector peptide, binds to two distinct receptors, the Ang type-1 receptor (AT1R) and the Ang type-2 receptor (AT2R) with high affinity (1,2). The vast majority of actions of Ang II are transmitted via AT1Rs, including cellular dedifferentiation and proliferation; vasoconstriction, reduction of vascular compliance, cardiac contractility, increased renal tubule sodium (Na+) reabsorption; aldosterone, vasopressin and endothelin secretion; salt appetite; thirst and activation of the sympathetic nervous system (1,2). In contrast, AT2Rs generally oppose the actions of Ang II via AT1Rs under most circumstances (1–4). Another major regulatory system in cardiovascular and renal physiology is the peripheral dopaminergic system. Dopamine is mainly synthesized in renal proximal tubule cells (RPTCs) via the decarboxylation of L-dihydroxyphenylalanine (L-DOPA) that has been filtered at the glomerulus and transported into the RPTC across the apical brush border (5). Synthesized DA exits the cell mainly across the apical plasma membrane into the lumen where it can bind to and activate specific DA D1-like receptors (D1-likeR: D1 and D5) (5,6). D1-like receptor activation induces vasodilation and inhibits renal Na+ reabsorption, actions which also oppose those of Ang II via AT1Rs. The purpose of this brief review is to summarize some of the key findings leading to our present concepts of AT2Rs and D1-like receptors that oppose the actions of Ang II via AT1Rs within the kidney.